Showing results (1451-1460 of 1,826) with videos related to
Sort By:
Pageof 183
Nature Plants|April 9, 2021
Plant flavones enrich rhizosphere Oxalobacteraceae to improve maize performance under nitrogen deprivationPeng Yu, Xiaoming He, Marcel Baer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP StudyAli Bazarbachi, Myriam Labopin, Nour Moukalled, et al.Bone Marrow Transplantation|August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMTArnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.Cancer Medicine|January 20, 2022
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemiaRama Al Hamed, Myriam Labopin, Etienne Daguindau, et al.Genes, Chromosomes & Cancer|April 18, 2019
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromesChristina Ganster, Catharina Müller-Thomas, Claudia Haferlach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNetTiziano Barbui, Giovanni Barosi, Gunnar Birgegard, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Jose A Perez-Simon, Han Myint, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.Blood|March 14, 2013
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 studyGösta Gahrton, Simona Iacobelli, Bo Björkstrand, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2020
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)Solange Peters, Enriqueta Felip, Urania Dafni, et al.Pageof 183